Variant report
Variant | esv3465268 |
---|---|
Chromosome Location | chr4:55998504-55998916 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180983520 | chr4:55998508-55998509 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184811856 | chr4:55998516-55998517 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572630160 | chr4:55998519-55998520 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190456545 | chr4:55998548-55998549 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs56104237 | chr4:55998590-55998591 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71202492 | chr4:55998591-55998592 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368229208 | chr4:55998622-55998623 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544856949 | chr4:55998745-55998746 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558293646 | chr4:55998747-55998748 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181641290 | chr4:55998842-55998843 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373589438 | chr4:55998889-55998890 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186758889 | chr4:55998902-55998903 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561034541 | chr4:55998906-55998907 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:55997400-55999200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr4:55997400-55999200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr4:55997600-55998600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:55997800-55999000 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr4:55997800-55999000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:55997800-56003000 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr4:55998000-55999000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr4:55998000-55999200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr4:55998400-55999200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
10 | chr4:55998400-55999400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr4:55998600-55999000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |